Form 4: BioAtla's Chief Medical Officer, Eric Sievers, Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Eric Sievers, Chief Medical Officer of BioAtla, Inc., reports a transaction involving the withholding of shares by the issuer to cover income tax obligations related to vesting restricted stock units.
Summary
- On February 29, 2024, BioAtla, Inc. withheld 572 shares of common stock from Eric Sievers, the Chief Medical Officer.
- The shares were withheld to satisfy income tax and withholding obligations related to the vesting and net settlement of previously reported restricted stock units.
- Following the transaction, Sievers beneficially owns 210,994 shares of BioAtla common stock directly.
Sentiment
Score: 7
Explanation: The document reflects a neutral event (tax withholding) related to executive compensation, so the sentiment is moderately positive as it indicates normal business operations.
Future Outlook
There are no forward-looking statements in this document.
Industry Context
This is a routine Form 4 filing related to executive compensation and tax obligations, common in publicly traded companies.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a standard procedure for tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/29/2024 | Transaction date: 572 shares withheld to cover tax obligations. |
| 03/01/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.